Fengxi Su
Impact in
- Cancer Research top 0.5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 1%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 25
- Cancer Cells and Metastasis 7
- HER2/EGFR in Cancer Research 5
- Chemokine receptors and signaling 4
- Co-authors
- Erwei Song (30 shared papers)Herui Yao (20 shared papers)Qiang Liu (16 shared papers)Shicheng Su (11 shared papers)Jianing Chen (7 shared papers)Di Huang (8 shared papers)Chang Gong (10 shared papers)Jianing Chen (8 shared papers)
- Journals
- PLoS ONE (5 papers)Oncotarget (5 papers)Cancer Cell (3 papers)BMC Cancer (3 papers)Journal of Surgical Research (3 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Fengxi Su
55 papers receiving 4.7k citations
Fengxi Su's Hit Papers
Peers
Comparison fields: 5 of 116
- Cancer Research 1.5k
- Oncology 1.9k
- Immunology 1.3k
- Molecular Biology 2.0k
- Pulmonary and Respiratory Medicine 336
Countries citing papers authored by Fengxi Su
This map shows the geographic impact of Fengxi Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengxi Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengxi Su more than expected).
Fields of papers citing papers by Fengxi Su
This network shows the impact of papers produced by Fengxi Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengxi Su. The network helps show where Fengxi Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Fengxi Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness Hit paper breakdown → | 2018 | 946 |
| 2 | A Positive Feedback Loop between Mesenchymal-like Cancer Cells and Macrophages Is Essential to Breast Cancer Metastasis Hit paper breakdown → | 2014 | 617 |
| 3 | CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis via PITPNM3 Hit paper breakdown → | 2011 | 513 |
| 4 | 2011 | 262 | |
| 5 | 2018 | 235 | |
| 6 | 2015 | 212 | |
| 7 | 2011 | 210 | |
| 8 | 2017 | 177 | |
| 9 | 2011 | 125 | |
| 10 | 2013 | 109 | |
| 11 | 2018 | 106 | |
| 12 | 2015 | 89 | |
| 13 | 2018 | 85 | |
| 14 | 2013 | 76 | |
| 15 | 2021 | 73 | |
| 16 | 2001 | 62 | |
| 17 | 2005 | 61 | |
| 18 | 2010 | 61 | |
| 19 | 2015 | 57 | |
| 20 | 2003 | 56 |
About Fengxi Su
Fengxi Su is a scholar working on Oncology, Molecular Biology, Cancer Research, Immunology and Pathology and Forensic Medicine, having authored 55 papers that have together received 4.7k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (7 papers), Breast Cancer Treatment Studies (6 papers), MicroRNA in disease regulation (6 papers), HER2/EGFR in Cancer Research (5 papers), Immune Cell Function and Interaction (4 papers), Immune cells in cancer (4 papers), Chemokine receptors and signaling (4 papers) and Cancer-related molecular mechanisms research (4 papers). The work is most often cited by research in Cancer Research (1.5k citations), Oncology (1.9k citations), Immunology (1.3k citations), Molecular Biology (2.0k citations) and Pulmonary and Respiratory Medicine (336 citations). Fengxi Su has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Erwei Song, Herui Yao, Qiang Liu, Shicheng Su, Jianing Chen, Di Huang, Chang Gong, Jianing Chen, Fei Chen and Xiuying Cui. Their work appears in journals such as PLoS ONE, Oncotarget, Cancer Cell, BMC Cancer and Journal of Surgical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.